B Cell-Mediated Immunity to Viruses
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: 19 February 2025 | Viewed by 191
Special Issue Editor
Special Issue Information
Dear Colleagues,
B cell-mediated humoral immune response, also known as antibody-mediated response, plays a critical role in host defense against invading pathogens and is a key determinant for the development of most effective vaccines. Studying broadly neutralizing antibodies and understanding the rules for eliciting broadly neutralizing B cell responses will help antibody-based therapies and vaccine development. In addition, antibody functions are varied, and not all pathogen-specific antibodies benefit the host. Hence, the scope of this topic is related to B cell development, function, epitopes and application in the face of infectious pathogens.
Prof. Dr. Haiyan Zhao
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- broadly neutralizing antibodies
- protective antibodies
- non-protective antibodies
- epitopes
- epitope-based vaccine design
- B cell development
- B cell repertoire
